check the thread by psychdoc! remember the combo geno I told you about? That is she.
http://hivandhepatitis.org/
the latest news from the conference in San Francisco are already out. Please check it out.
Thanks so much! Going to go read now!
How YOU doin? ;-)
I am a new member of this web sit and it has been so helpful. I am waiting also and it is killing me I had a sonogram also and got the results. It showed a fatty liver. I am waiting to have my Liver biopsy. I see my MD on the 16th and the biopsy will be scheduled at that time. At what point did you have to go on disability? The other thing is me being overweight. I have read that keeping your weight down is very important. I am trying so hard to loose these 50 extra pounds I am carry around and being stressed out does not help. I am one of those people who will eat when stressed instead of not eating.
Just for a thumbnail - I think you're looking at dosing levels that are being scrapped. They tried 3 levels and two seemed not quite enough to finish the job. I don't think there was a bounce back in the optimally dosed group. More info on the 1 hr webcast available the the Vertex site.
This is a response I just got from the Chair of the Canadian National Hepatitis C Steering Committee regarding this mornings Vertex and others news:
"I know all would love to be able to post that a cure is available tomorrow, but things take time. The Hepatitis C virus is a pretty smart cookie. I'm warmed to see so much research on this virus in many ways. Not only medications directed at killing or controlling the virus, but also quality of life issues. There is so much emphasis on the word treatment that only deals with stopping or controlling the virus. There are so many other issues affecting those impacted with this disease. It ravages many parts of the body, may enhance other autoimmune disorders etc. These also have a place in the "treatment" envelope, but are usually set aside for current interferon combo treatments. Many of the new drugs in development are picked up by readers who often fail to distinguish between a security and exchange release, which is usually enhanced as to seek funding for more research and thus a profit for investors. One has to be careful when reading these releases as they are directed at the security analysts and investors rather than disease group consumers. Hopefully the NS3 inhibitors will show some promise as we have had only interferon in a few different guises, combined with a nuke for the past 10 years or so. There are many working long and often fruitless hours, to seek a cure for this disease. One day soon I hope it will be on our doorstep."